3-BROMO-5-METHYL-PYRAZOLO[1,5-A]PYRIMIDINE, 95.0%, 1g

1-Iodo-2-methylbutane, 97%, 25g

Ethyl 2-(1H-1,2,3-triazol-1-yl)acetate, 98%, 250mg

Ethyl 7-oxononanoate, 97.0%, 1g

5-(2,4-Dibromo-6-fluorophenyl)oxazole, 98%, 500mg

3-[3-(1-Methylpiperidin-4-yl)propoxy]propionitrile, 1g

4-(1-Hydroxyethyl)-2-methoxyphenol, 95.0%, 25g

Methyl 5-formyl-1-isopropyl-1H-pyrazole-3-carboxylate, 97%, 5g

3 mm NMR Economy Sample Tube w/o Cap, 4" L, High-Throughput, 100x1ea

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(pyridin-3-yl)phenyl)propanoic acid, 97%, 250mg

2-(Methylthio)benzimidazole, 95.0%, 1g

4-Bromo-2-fluoro-6-methylbenzoic acid, 95.0%, 25g

4H-1-Benzopyran-6-carboxamide, 8-[(1R)-1-[(3,5-difluorophenyl)amino]ethyl]-N,N-dimethyl-2-(4-morpholinyl)-4-oxo-, 97%, 25mg